ArticlePeerJ2019

Network-based approach to identify biomarkers predicting response and prognosis for HER2-negative breast cancer treatment with taxane-anthracycline neoadjuvant chemotherapy.

Cui Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.